Inflammatory profiles and checkpoint landsscape(PMID: 32201203)
seven metagenes
HCK,IgG,Interferon,LCK,MHC-I,MHC-II,STAT1

B7-CD28家族
PDL1,PDL2,ICOSLG,B7-H3,HHLA2,CTLA4,ICOS,PD-1,TMIGD2
TNF超家族
BTLA,LIGHT,CD40,OX40,4-1BB,CD27,CD40LG,OX40L,4-1BB-L,CD77,AITR
其他免疫检查点
TIM3,IDO1,LAG3,FGL1,CD39,CD73,SIGLEC15,VSIR,NCR3

CIBERSORT
包含LM22(22种免疫细胞的表达矩阵)

tumors associated infiltrating lymphocytes (TILs)
肿瘤相关浸润淋巴细胞,包含24种类型,具体细胞标志物参见下面文献附表2:
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
免疫检查点

PMID: 33879726
免疫检查点(PD1, PDL1, LAG3, HAVCR2, BTLA, CTLA4)
免疫刺激和抑制因子
33 immunostimulators (CD27, VSIR, CD28, CD40, CD40LG, CD48, CD80, CD86, CXCL12, CXCR4, ENTPD1, HHLA2, ICOS, ICOSLG, IL2RA, IL6, IL6R, KLRK1, LTA, PVR, TMEM173, TMIGD2, TNFRSF13B, TNFRSF13C, TNFRSF14, TNFRSF17, TNFRSF25, TNFRSF8, TNFSF13, TNFSF13B, TNFSF14, TNFSF15, and TNFSF9) and 17 immunoinhibitors (ADORA2A, BTLA, CD160, CD244, CD274, CD96, CSF1R, CTLA4, HAVCR2, IL10, KDR, LGALS9, PDCD1, PDCD1LG2, NECTIN2, TGFB1, and TIGIT)

网友评论